Impact of metaplastic histology (MpBC) in triple-negative breast cancer (TNBC) patients (pts) receiving neoadjuvant systemic therapy (NAST)

被引：16
|
作者：
Yam, Clinton
Hess, Kenneth R.
Litton, Jennifer Keating
Yang, Wei Tse
Santiago, Lumarie
Candelaria, Rosalind P.
Mittendorf, Elizabeth A.
Murthy, Rashmi Krishna
Damodaran, Senthil
Helgason, Thorunn
Huo, Lei
Thompson, Alastair Mark
Barton, Michelle
Huang, Monica L.
Arribas, Elsa M.
Lane, Deanna L.
Rauch, Gaiane M.
Adrada, Beatriz E.
Gilcrease, Michael Z.
Moulder, Stacy L.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.593
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
593
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer
    Yam, Clinton
    Abuhadra, Nour
    Sun, Ryan
    Adrada, Beatriz E.
    Ding, Qing-Qing
    White, Jason B.
    Ravenberg, Elizabeth E.
    Clayborn, Alyson R.
    Valero, Vicente
    Tripathy, Debu
    Damodaran, Senthilkumar
    Arun, Banu K.
    Litton, Jennifer K.
    Ueno, Naoto T.
    Murthy, Rashmi K.
    Lim, Bora
    Baez, Luis
    Li, Xiaoxian
    Buzdar, Aman U.
    Hortobagyi, Gabriel N.
    Thompson, Alistair M.
    A. Mittendori, Elizabeth
    Rauch, Gaiane M.
    Candelaria, Rosalind P.
    Huo, Lei
    Moulder, Stacy L.
    Chang, Jeffrey T.
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (13) : 2878 - 2889
  • [32] Efficacy and safety of neoadjuvant therapy for Triple-Negative Breast Cancer (TNBC): a Bayesian network meta-analysis
    Yu, Y.
    Zhang, J.
    Lin, Y.
    Kang, S.
    Lv, X.
    Song, C.
    [J]. BREAST, 2021, 56 : S50 - S50
  • [33] The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)
    Michaels, Elena
    Chen, Nan
    Nanda, Rita
    [J]. CLINICAL BREAST CANCER, 2024, 24 (04) : 263 - 270
  • [34] Locoregional recurrence in patients with early-stage triple-negative breast cancer receiving neoadjuvant systemic therapy: Patient characteristics and clinical outcomes
    Haiderali, Amin
    Rhodes, Whitney C.
    Gautam, Santosh
    Huang, Min
    Sieluk, Jan
    Skinner, Karen E.
    Schwartzberg, Lee S.
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [35] Phosphoproteomic portraits of triple-negative breast cancer (TNBC)
    Quintela-Fandino, Miguel
    Zagorac, Ivana
    Lopez-Acosta, Jose Francisco
    Gomez, Gonzalo
    Pisano, David G.
    Munoz, Javier
    Manso, Luis
    Alonso, Soledad
    Penning, Renske
    Altelaar, Maarten
    Heck, Albert J. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] Lipogenesis inhibition in triple-negative breast cancer (TNBC)
    Giro-Perafita, Ariadna
    Palomeras, Sonia
    Polonio, Emma
    Ciurana, Joaquim
    Vinas, Gemma
    Puig, Teresa
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S58 - S58
  • [37] Prognostic Factors for Triple-Negative Breast Cancer Patients Receiving Preoperative Systemic Chemotherapy
    Asaga, Sota
    Kinoshita, Takayuki
    Hojo, Takashi
    Suzuki, Junko
    Jimbo, Kenjiro
    Tsuda, Hitoshi
    [J]. CLINICAL BREAST CANCER, 2013, 13 (01) : 40 - 46
  • [38] Copper chaperons as novel targets for therapy in triple-negative breast cancer (TNBC)
    Karginova, O.
    Song, A.
    Wang, J.
    Luo, C.
    Jiang, H.
    He, C.
    Olopade, O. I.
    [J]. CANCER RESEARCH, 2016, 76
  • [39] Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC)
    Kanugo, Abhishek
    Gautam, Rupesh K.
    Kamal, Mohammad Amjad
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2022, 23 (13) : 1581 - 1595
  • [40] Impact of radiation therapy on survival in patients with triple-negative breast cancer
    Steward, Lauren T.
    Gao, Feng
    Taylor, Marie A.
    Margenthaler, Julie A.
    [J]. ONCOLOGY LETTERS, 2014, 7 (02) : 548 - 552
12345